Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 24/04/15

Trade details

Type: Insider sale
Amount: $126,276.35
Shares · price: 5,045 sh · $25.03 a share
Held after: 138.43 sh
Stock: Enliven Therapeutics ELVN
Person: Richard A. HeymanDirector
Trade date: 24/04/11
Filed: 24/04/15
Days to filing: 4 days

Sold 97.3% of holdings

Share of holding sold: 97.3%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/12~24/05/11

Richard A. Heyman's recent trades

Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$45.2K
3,500 sh
$45.2K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$41.3K
3,200 sh
$41.3K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$109.1K
8,100 sh
$109.1K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$102.4K
7,600 sh
$102.4K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04